ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract B005: A phase I study of A166, a novel anti-HER2 antibody-drug conjugate (ADC), in patients with locally advanced/metastatic solid tumors
Mapping Intimacies
◽
10.1158/1535-7163.targ-19-b005
◽
2019
◽
Cited By ~ 1
Author(s):
Diana M Lopez
◽
Minal Barve
◽
Judy Wang
◽
Andrea J. Bullock
◽
Eirini Pectasides
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Locally Advanced
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Related Documents
Cited By
References
A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870).
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.2511
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. 2511-2511
◽
Cited By ~ 15
Author(s):
Carlos Alberto Gomez-Roca
◽
Valentina Boni
◽
Victor Moreno
◽
John Charles Morris
◽
Jean-Pierre Delord
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Advanced Solid Tumors
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
472 A phase I study of IMGN388, an antibody drug conjugate targeting av integrin, in patients with solid tumors
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(10)72179-0
◽
2010
◽
Vol 8
(7)
◽
pp. 152
◽
Cited By ~ 2
Author(s):
J. Bendell
◽
K. Moore
◽
A. Qin
◽
D. Johnson
◽
J. Schindler
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
556TiP A phase I study of SGN-STNV, a novel antibody–drug conjugate targeting sialyl-thomsen-nouveau antigen (STn), in adults with advanced solid tumors (SGNSTNV-001)
Annals of Oncology
◽
10.1016/j.annonc.2021.08.1078
◽
2021
◽
Vol 32
◽
pp. S613-S614
Author(s):
N.J. Lakhani
◽
I. Braña
◽
V.K. Chiu
◽
A. Dowlati
◽
E.K. Lee
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Advanced Solid Tumors
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors
International Journal of Cancer
◽
10.1002/ijc.32154
◽
2019
◽
Vol 145
(7)
◽
pp. 1798-1808
◽
Cited By ~ 5
Author(s):
Ignacio Garrido-Laguna
◽
Ian Krop
◽
Howard A. Burris
◽
Erika Hamilton
◽
Fadi Braiteh
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Advanced Solid Tumors
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
Investigational New Drugs
◽
10.1007/s10637-016-0336-9
◽
2016
◽
Vol 34
(3)
◽
pp. 290-299
◽
Cited By ~ 27
Author(s):
Manisha H. Shah
◽
Paul Lorigan
◽
Mary E. R. O’Brien
◽
Frank V. Fossella
◽
Kathleen N. Moore
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (Pts) with solid tumors
Annals of Oncology
◽
10.1093/annonc/mdw368.01
◽
2016
◽
Vol 27
◽
pp. vi114
Author(s):
S. Modi
◽
J.P. Eder
◽
P. Lorusso
◽
C. Weekes
◽
S. Chandarlapaty
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Lymphocyte Antigen
◽
Drug Conjugate
◽
Tumor Associated Antigen
◽
Complex Locus
◽
Antibody Drug
Download Full-text
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-19-0711
◽
2019
◽
Vol 25
(23)
◽
pp. 6986-6994
◽
Cited By ~ 19
Author(s):
Brad S. Kahl
◽
Mehdi Hamadani
◽
John Radford
◽
Carmelo Carlo-Stella
◽
Paolo Caimi
◽
...
Keyword(s):
Phase I
◽
B Cell
◽
Hodgkin Lymphoma
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Non Hodgkin Lymphoma
◽
Antibody Drug
Download Full-text
A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors
Investigational New Drugs
◽
10.1007/s10637-019-00754-y
◽
2019
◽
Vol 38
(1)
◽
pp. 120-130
◽
Cited By ~ 6
Author(s):
Lee S. Rosen
◽
Robert Wesolowski
◽
Raffaele Baffa
◽
Kai-Hsin Liao
◽
Steven Y. Hua
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Antibody Drug Conjugate
◽
Dose Escalation Study
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma
Investigational New Drugs
◽
10.1007/s10637-019-00832-1
◽
2019
◽
Vol 38
(3)
◽
pp. 844-854
◽
Cited By ~ 4
Author(s):
Shahneen Sandhu
◽
Catriona M. McNeil
◽
Patricia LoRusso
◽
Manish R. Patel
◽
Omar Kabbarah
◽
...
Keyword(s):
Phase I
◽
Uveal Melanoma
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Endothelin B Receptor
◽
Receptor Antibody
◽
Drug Conjugate
◽
Endothelin B
◽
Antibody Drug
Download Full-text
A phase I study of trastuzumab-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with advanced HER2+ breast cancer (BC)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.1028
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 1028-1028
◽
Cited By ~ 20
Author(s):
M. Beeram
◽
H. A. Burris
◽
S. Modi
◽
M. Birkner
◽
S. Girish
◽
...
Keyword(s):
Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Her2 Breast Cancer
◽
Antibody Drug
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close